Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FBE52
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,230
Award facts
- Contract value 100% obligated
- $29,229.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,229.87 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300mg dose in 2-pen/mL format. The contract is a firm fixed-price delivery order with an ultimate completion date of September 8, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and healthcare systems, supplying an extensive range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The DLA Troop Support Medical IDC enables the company to support military healthcare programs worldwide, serving customers including the Defense Health Agency and the U.S. Coast Guard. This specific delivery order for Cosentyx, a specialty immunosuppressant medication used for inflammatory conditions, reflects AmerisourceBergen's ongoing role in meeting federal pharmaceutical procurement requirements through its flexible contract vehicle.
Quick answers
Who was awarded contract SPE2DB25FBE52?
SPE2DB25FBE52 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 5, 2025.
How much is contract SPE2DB25FBE52 worth?
The government has obligated $29,230 on SPE2DB25FBE52.
Is contract SPE2DB25FBE52 an order under another contract?
Yes. SPE2DB25FBE52 is a delivery order under SPE2DB22D3009, an indefinite delivery contract.
Was contract SPE2DB25FBE52 competed?
The extent of competition for SPE2DB25FBE52 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award